Zobrazeno 91 - 100
of 244
pro vyhledávání: '"Bertagnolli MM"'
Autor:
Bertagnolli MM; Brigham & Women's Hospital, Boston, Massachusetts., Blanke CD; Portland, Oregon., Curran WJ; Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia., Hawkins DS; Division of Hematology/Oncology, Seattle Children's Hospital, Seattle, Washington., Mannel RS; Division of Gynecologic Oncology, University of Oklahoma Stevenson Cancer Center, Oklahoma City, Oklahoma., O'Dwyer PJ; Department Hematology/Oncology, University of Pennsylvania Abramson Cancer Center, Philadelphia, Pennsylvania., Schnall MD; Department of Radiology, University of Pennsylvania Abramson Cancer Center, Philadelphia, Pennsylvania., Wolmark N; Department of Surgery, Division of Surgical Oncology, University of Pittsburgh, Pittsburgh, Pennsylvania.
Publikováno v:
Cancer [Cancer] 2020 Dec 01; Vol. 126 (23), pp. 5022-5029. Date of Electronic Publication: 2020 Sep 24.
Autor:
Lyu HG; Departments of Surgery, Boston, Massachusetts, USA., Saadat LV; Departments of Surgery, Boston, Massachusetts, USA., Bertagnolli MM; Departments of Surgery, Boston, Massachusetts, USA.; Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Wang J; Departments of Surgery, Boston, Massachusetts, USA.; Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Baldini EH; Radiation Oncology, Boston, Massachusetts, USA.; Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Stopfkuchen-Evans M; Anesthesiology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Bleday R; Departments of Surgery, Boston, Massachusetts, USA.; Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA., Raut CP; Departments of Surgery, Boston, Massachusetts, USA.; Radiation Oncology, Boston, Massachusetts, USA.
Publikováno v:
The British journal of surgery [Br J Surg] 2020 Nov; Vol. 107 (12), pp. 1667-1672. Date of Electronic Publication: 2020 Jul 03.
Autor:
Bertagnolli MM; Brigham & Women's Hospital and Dana-Farber Cancer Institute, Boston, MA.
Publikováno v:
JCO oncology practice [JCO Oncol Pract] 2020 Jul; Vol. 16 (7), pp. 405-407. Date of Electronic Publication: 2020 Jun 23.
Autor:
Bertagnolli MM; Brigham and Women's Hospital, Alliance for Clinical Trials in Oncology Foundation, Boston, MA, USA., Anderson B; MITRE Corporation, Bedford, MA, USA., Quina A; MITRE Corporation, Bedford, MA, USA., Piantadosi S; Brigham and Women's Hospital, Alliance for Clinical Trials in Oncology Foundation, Boston, MA, USA.
Publikováno v:
Clinical trials (London, England) [Clin Trials] 2020 Jun; Vol. 17 (3), pp. 237-242. Date of Electronic Publication: 2020 Apr 08.
Autor:
Bertagnolli MM; Brigham and Women's Hospital, Boston, MA, USA., Anderson B; The MITRE Corporation, Bedford, MA, USA., Quina A; The MITRE Corporation, Bedford, MA, USA., Piantadosi S; Brigham and Women's Hospital, Boston, MA, USA.
Publikováno v:
Clinical trials (London, England) [Clin Trials] 2020 Jun; Vol. 17 (3), pp. 251-252. Date of Electronic Publication: 2020 Apr 08.
Autor:
Bertagnolli MM; Brigham and Women's Hospital, and the Alliance for Clinical Trials in Oncology, Boston, MA., Anderson B; MITRE Corporation, Bedford, MA., Norsworthy K; US Food and Drug Administration, Silver Spring, MD., Piantadosi S; Brigham and Women's Hospital, and the Alliance for Clinical Trials in Oncology, Boston, MA., Quina A; MITRE Corporation, Bedford, MA., Schilsky RL; American Society of Clinical Oncology, Alexandria, VA., Miller RS; American Society of Clinical Oncology, Alexandria, VA., Khozin S; US Food and Drug Administration, Silver Spring, MD.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2020 May 10; Vol. 38 (14), pp. 1602-1607. Date of Electronic Publication: 2020 Mar 25.
Autor:
Markham MJ; University of Florida, Gainesville, FL., Wachter K; American Society of Clinical Oncology, Alexandria, VA., Agarwal N; Huntsman Cancer Institute, Salt Lake City, UT., Bertagnolli MM; Dana-Farber/Brigham and Women's Cancer Center, Boston, MA., Chang SM; University of California, San Francisco, CA., Dale W; City of Hope National Medical Center, Duarte, CA., Diefenbach CSM; New York University Cancer Center, New York, NY., Rodriguez-Galindo C; St Jude Children's Research Hospital, Memphis, TN., George DJ; Duke Cancer Center, Durham, NC., Gilligan TD; Cleveland Clinic Taussig Cancer Institute, Cleveland, OH., Harvey RD; Winship Cancer Institute at Emory University, Atlanta, GA., Johnson ML; Sarah Cannon Research Institute, Nashville, TN., Kimple RJ; University of Wisconsin, Madison, WI., Knoll MA; Hackensack University Medical Center, Hackensack, NJ., LoConte N; University of Wisconsin, Madison, WI., Maki RG; Northwell Health/Monter Cancer Center and Cold Spring Harbor Laboratory, Lake Success, NY., Meisel JL; Winship Cancer Institute at Emory University, Atlanta, GA., Meyerhardt JA; Dana-Farber Cancer Institute, Boston, MA., Pennell NA; Cleveland Clinic Taussig Cancer Institute, Cleveland, OH., Rocque GB; University of Alabama at Birmingham, Birmingham, AL., Sabel MS; University of Michigan, Ann Arbor, MI., Schilsky RL; American Society of Clinical Oncology, Alexandria, VA., Schneider BJ; University of Michigan, Ann Arbor, MI., Tap WD; Memorial Sloan Kettering Cancer Center, New York, NY., Uzzo RG; Fox Chase Cancer Center, Philadelphia, PA., Westin SN; University of Texas MD Anderson Cancer Center, Houston, TX.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2020 Apr 01; Vol. 38 (10), pp. 1081. Date of Electronic Publication: 2020 Feb 04.
Autor:
Abou-Alfa GK; Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medical College, Cornell University, New York, New York., Shi Q; Alliance Statistics and Data Center, Mayo Clinic, Rochester, Minnesota., Knox JJ; Princess Margaret Cancer Centre, Toronto, Ontario, Canada., Kaubisch A; Montefiore Medical Center, New York, New York., Niedzwiecki D; Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina., Posey J; Thomas Jefferson University, Philadelphia, Pennsylvania., Tan BR Jr; Washington University School of Medicine, St Louis, Missouri., Kavan P; McGill University, Montreal, Quebec, Canada., Goel R; Ottawa Hospital, Ottawa, Ontario, Canada., Lammers PE; Meharry Medical College, Nashville, Tennessee., Bekaii-Saab TS; Mayo Clinic, Scottsdale, Arizona., Tam VC; Tom Baker Cancer Centre, Calgary, Alberta, Canada., Rajdev L; Montefiore Medical Center, New York, New York., Kelley RK; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco., El Dika I; Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medical College, Cornell University, New York, New York., Zemla T; Alliance Statistics and Data Center, Mayo Clinic, Rochester, Minnesota., Potaracke RI; Alliance Statistics and Data Center, Mayo Clinic, Rochester, Minnesota., Balletti J; Memorial Sloan Kettering Cancer Center, New York, New York., El-Khoueiry AB; Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles., Harding JJ; Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medical College, Cornell University, New York, New York., Suga JM; Kaiser Permanente Vallejo Medical Center, Vallejo, California., Schwartz LH; Columbia University Medical Center, New York-Presbyterian Hospital, New York, New York., Goldberg RM; West Virginia University Cancer Institute, Morgantown., Bertagnolli MM; Brigham and Women's Hospital, Boston, Massachusetts., Meyerhardt J; Dana-Farber Cancer Institute, Boston, Massachusetts., O'Reilly EM; Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell Medical College, Cornell University, New York, New York., Venook AP; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco.
Publikováno v:
JAMA oncology [JAMA Oncol] 2019 Nov 01; Vol. 5 (11), pp. 1582-1588.
Autor:
Bertagnolli MM; Brigham and Women's Hospital, Boston, MA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2019 Sep 10; Vol. 37 (26), pp. 2301-2305. Date of Electronic Publication: 2019 Jul 25.
Autor:
Innocenti F; Federico Innocenti, MD, PhD, University of North Carolina at Chapel Hill, Chapel Hill, NC; Fang-Shu Ou, PhD, Mayo Clinic Minnesota, Rochester, MN; Xueping Qu, PhD, Genentech, South San Francisco, CA; Tyler Zemla, MS, Mayo Clinic Minnesota, Rochester, MN; Donna Niedzwiecki, PhD, Duke University, Durham, NC; Rachel Tam, PhD and Shilpi Mahajan, PhD, Genentech, South San Francisco, CA; Richard M. Goldberg, MD, West Virginia University Cancer Institute, Morgantown, WV; Monica M. Bertagnolli, MD, Dana-Farber Cancer Institute, Boston, MA; Charles David Blanke, MD, Oregon Health and Science University Hospital, Portland, OR; Hanna Sanoff, MD, University of North Carolina at Chapel Hill, Chapel Hill, NC; James Atkins, MD, Bon Secours Health System, Richmond, VA; Blasé Polite, MD, University of Chicago Medical Center, Chicago, IL; Alan P. Venook, MD, University of California San Francisco, San Francisco, CA; Heinz-Josef Lenz, MD, University of Southern California, Los Angeles, CA; and Omar Kabbarah, PhD, ORIC Pharmaceuticals, South San Francisco, CA., Ou FS; Federico Innocenti, MD, PhD, University of North Carolina at Chapel Hill, Chapel Hill, NC; Fang-Shu Ou, PhD, Mayo Clinic Minnesota, Rochester, MN; Xueping Qu, PhD, Genentech, South San Francisco, CA; Tyler Zemla, MS, Mayo Clinic Minnesota, Rochester, MN; Donna Niedzwiecki, PhD, Duke University, Durham, NC; Rachel Tam, PhD and Shilpi Mahajan, PhD, Genentech, South San Francisco, CA; Richard M. Goldberg, MD, West Virginia University Cancer Institute, Morgantown, WV; Monica M. Bertagnolli, MD, Dana-Farber Cancer Institute, Boston, MA; Charles David Blanke, MD, Oregon Health and Science University Hospital, Portland, OR; Hanna Sanoff, MD, University of North Carolina at Chapel Hill, Chapel Hill, NC; James Atkins, MD, Bon Secours Health System, Richmond, VA; Blasé Polite, MD, University of Chicago Medical Center, Chicago, IL; Alan P. Venook, MD, University of California San Francisco, San Francisco, CA; Heinz-Josef Lenz, MD, University of Southern California, Los Angeles, CA; and Omar Kabbarah, PhD, ORIC Pharmaceuticals, South San Francisco, CA., Qu X; Federico Innocenti, MD, PhD, University of North Carolina at Chapel Hill, Chapel Hill, NC; Fang-Shu Ou, PhD, Mayo Clinic Minnesota, Rochester, MN; Xueping Qu, PhD, Genentech, South San Francisco, CA; Tyler Zemla, MS, Mayo Clinic Minnesota, Rochester, MN; Donna Niedzwiecki, PhD, Duke University, Durham, NC; Rachel Tam, PhD and Shilpi Mahajan, PhD, Genentech, South San Francisco, CA; Richard M. Goldberg, MD, West Virginia University Cancer Institute, Morgantown, WV; Monica M. Bertagnolli, MD, Dana-Farber Cancer Institute, Boston, MA; Charles David Blanke, MD, Oregon Health and Science University Hospital, Portland, OR; Hanna Sanoff, MD, University of North Carolina at Chapel Hill, Chapel Hill, NC; James Atkins, MD, Bon Secours Health System, Richmond, VA; Blasé Polite, MD, University of Chicago Medical Center, Chicago, IL; Alan P. Venook, MD, University of California San Francisco, San Francisco, CA; Heinz-Josef Lenz, MD, University of Southern California, Los Angeles, CA; and Omar Kabbarah, PhD, ORIC Pharmaceuticals, South San Francisco, CA., Zemla T; Federico Innocenti, MD, PhD, University of North Carolina at Chapel Hill, Chapel Hill, NC; Fang-Shu Ou, PhD, Mayo Clinic Minnesota, Rochester, MN; Xueping Qu, PhD, Genentech, South San Francisco, CA; Tyler Zemla, MS, Mayo Clinic Minnesota, Rochester, MN; Donna Niedzwiecki, PhD, Duke University, Durham, NC; Rachel Tam, PhD and Shilpi Mahajan, PhD, Genentech, South San Francisco, CA; Richard M. Goldberg, MD, West Virginia University Cancer Institute, Morgantown, WV; Monica M. Bertagnolli, MD, Dana-Farber Cancer Institute, Boston, MA; Charles David Blanke, MD, Oregon Health and Science University Hospital, Portland, OR; Hanna Sanoff, MD, University of North Carolina at Chapel Hill, Chapel Hill, NC; James Atkins, MD, Bon Secours Health System, Richmond, VA; Blasé Polite, MD, University of Chicago Medical Center, Chicago, IL; Alan P. Venook, MD, University of California San Francisco, San Francisco, CA; Heinz-Josef Lenz, MD, University of Southern California, Los Angeles, CA; and Omar Kabbarah, PhD, ORIC Pharmaceuticals, South San Francisco, CA., Niedzwiecki D; Federico Innocenti, MD, PhD, University of North Carolina at Chapel Hill, Chapel Hill, NC; Fang-Shu Ou, PhD, Mayo Clinic Minnesota, Rochester, MN; Xueping Qu, PhD, Genentech, South San Francisco, CA; Tyler Zemla, MS, Mayo Clinic Minnesota, Rochester, MN; Donna Niedzwiecki, PhD, Duke University, Durham, NC; Rachel Tam, PhD and Shilpi Mahajan, PhD, Genentech, South San Francisco, CA; Richard M. Goldberg, MD, West Virginia University Cancer Institute, Morgantown, WV; Monica M. Bertagnolli, MD, Dana-Farber Cancer Institute, Boston, MA; Charles David Blanke, MD, Oregon Health and Science University Hospital, Portland, OR; Hanna Sanoff, MD, University of North Carolina at Chapel Hill, Chapel Hill, NC; James Atkins, MD, Bon Secours Health System, Richmond, VA; Blasé Polite, MD, University of Chicago Medical Center, Chicago, IL; Alan P. Venook, MD, University of California San Francisco, San Francisco, CA; Heinz-Josef Lenz, MD, University of Southern California, Los Angeles, CA; and Omar Kabbarah, PhD, ORIC Pharmaceuticals, South San Francisco, CA., Tam R; Federico Innocenti, MD, PhD, University of North Carolina at Chapel Hill, Chapel Hill, NC; Fang-Shu Ou, PhD, Mayo Clinic Minnesota, Rochester, MN; Xueping Qu, PhD, Genentech, South San Francisco, CA; Tyler Zemla, MS, Mayo Clinic Minnesota, Rochester, MN; Donna Niedzwiecki, PhD, Duke University, Durham, NC; Rachel Tam, PhD and Shilpi Mahajan, PhD, Genentech, South San Francisco, CA; Richard M. Goldberg, MD, West Virginia University Cancer Institute, Morgantown, WV; Monica M. Bertagnolli, MD, Dana-Farber Cancer Institute, Boston, MA; Charles David Blanke, MD, Oregon Health and Science University Hospital, Portland, OR; Hanna Sanoff, MD, University of North Carolina at Chapel Hill, Chapel Hill, NC; James Atkins, MD, Bon Secours Health System, Richmond, VA; Blasé Polite, MD, University of Chicago Medical Center, Chicago, IL; Alan P. Venook, MD, University of California San Francisco, San Francisco, CA; Heinz-Josef Lenz, MD, University of Southern California, Los Angeles, CA; and Omar Kabbarah, PhD, ORIC Pharmaceuticals, South San Francisco, CA., Mahajan S; Federico Innocenti, MD, PhD, University of North Carolina at Chapel Hill, Chapel Hill, NC; Fang-Shu Ou, PhD, Mayo Clinic Minnesota, Rochester, MN; Xueping Qu, PhD, Genentech, South San Francisco, CA; Tyler Zemla, MS, Mayo Clinic Minnesota, Rochester, MN; Donna Niedzwiecki, PhD, Duke University, Durham, NC; Rachel Tam, PhD and Shilpi Mahajan, PhD, Genentech, South San Francisco, CA; Richard M. Goldberg, MD, West Virginia University Cancer Institute, Morgantown, WV; Monica M. Bertagnolli, MD, Dana-Farber Cancer Institute, Boston, MA; Charles David Blanke, MD, Oregon Health and Science University Hospital, Portland, OR; Hanna Sanoff, MD, University of North Carolina at Chapel Hill, Chapel Hill, NC; James Atkins, MD, Bon Secours Health System, Richmond, VA; Blasé Polite, MD, University of Chicago Medical Center, Chicago, IL; Alan P. Venook, MD, University of California San Francisco, San Francisco, CA; Heinz-Josef Lenz, MD, University of Southern California, Los Angeles, CA; and Omar Kabbarah, PhD, ORIC Pharmaceuticals, South San Francisco, CA., Goldberg RM; Federico Innocenti, MD, PhD, University of North Carolina at Chapel Hill, Chapel Hill, NC; Fang-Shu Ou, PhD, Mayo Clinic Minnesota, Rochester, MN; Xueping Qu, PhD, Genentech, South San Francisco, CA; Tyler Zemla, MS, Mayo Clinic Minnesota, Rochester, MN; Donna Niedzwiecki, PhD, Duke University, Durham, NC; Rachel Tam, PhD and Shilpi Mahajan, PhD, Genentech, South San Francisco, CA; Richard M. Goldberg, MD, West Virginia University Cancer Institute, Morgantown, WV; Monica M. Bertagnolli, MD, Dana-Farber Cancer Institute, Boston, MA; Charles David Blanke, MD, Oregon Health and Science University Hospital, Portland, OR; Hanna Sanoff, MD, University of North Carolina at Chapel Hill, Chapel Hill, NC; James Atkins, MD, Bon Secours Health System, Richmond, VA; Blasé Polite, MD, University of Chicago Medical Center, Chicago, IL; Alan P. Venook, MD, University of California San Francisco, San Francisco, CA; Heinz-Josef Lenz, MD, University of Southern California, Los Angeles, CA; and Omar Kabbarah, PhD, ORIC Pharmaceuticals, South San Francisco, CA., Bertagnolli MM; Federico Innocenti, MD, PhD, University of North Carolina at Chapel Hill, Chapel Hill, NC; Fang-Shu Ou, PhD, Mayo Clinic Minnesota, Rochester, MN; Xueping Qu, PhD, Genentech, South San Francisco, CA; Tyler Zemla, MS, Mayo Clinic Minnesota, Rochester, MN; Donna Niedzwiecki, PhD, Duke University, Durham, NC; Rachel Tam, PhD and Shilpi Mahajan, PhD, Genentech, South San Francisco, CA; Richard M. Goldberg, MD, West Virginia University Cancer Institute, Morgantown, WV; Monica M. Bertagnolli, MD, Dana-Farber Cancer Institute, Boston, MA; Charles David Blanke, MD, Oregon Health and Science University Hospital, Portland, OR; Hanna Sanoff, MD, University of North Carolina at Chapel Hill, Chapel Hill, NC; James Atkins, MD, Bon Secours Health System, Richmond, VA; Blasé Polite, MD, University of Chicago Medical Center, Chicago, IL; Alan P. Venook, MD, University of California San Francisco, San Francisco, CA; Heinz-Josef Lenz, MD, University of Southern California, Los Angeles, CA; and Omar Kabbarah, PhD, ORIC Pharmaceuticals, South San Francisco, CA., Blanke CD; Federico Innocenti, MD, PhD, University of North Carolina at Chapel Hill, Chapel Hill, NC; Fang-Shu Ou, PhD, Mayo Clinic Minnesota, Rochester, MN; Xueping Qu, PhD, Genentech, South San Francisco, CA; Tyler Zemla, MS, Mayo Clinic Minnesota, Rochester, MN; Donna Niedzwiecki, PhD, Duke University, Durham, NC; Rachel Tam, PhD and Shilpi Mahajan, PhD, Genentech, South San Francisco, CA; Richard M. Goldberg, MD, West Virginia University Cancer Institute, Morgantown, WV; Monica M. Bertagnolli, MD, Dana-Farber Cancer Institute, Boston, MA; Charles David Blanke, MD, Oregon Health and Science University Hospital, Portland, OR; Hanna Sanoff, MD, University of North Carolina at Chapel Hill, Chapel Hill, NC; James Atkins, MD, Bon Secours Health System, Richmond, VA; Blasé Polite, MD, University of Chicago Medical Center, Chicago, IL; Alan P. Venook, MD, University of California San Francisco, San Francisco, CA; Heinz-Josef Lenz, MD, University of Southern California, Los Angeles, CA; and Omar Kabbarah, PhD, ORIC Pharmaceuticals, South San Francisco, CA., Sanoff H; Federico Innocenti, MD, PhD, University of North Carolina at Chapel Hill, Chapel Hill, NC; Fang-Shu Ou, PhD, Mayo Clinic Minnesota, Rochester, MN; Xueping Qu, PhD, Genentech, South San Francisco, CA; Tyler Zemla, MS, Mayo Clinic Minnesota, Rochester, MN; Donna Niedzwiecki, PhD, Duke University, Durham, NC; Rachel Tam, PhD and Shilpi Mahajan, PhD, Genentech, South San Francisco, CA; Richard M. Goldberg, MD, West Virginia University Cancer Institute, Morgantown, WV; Monica M. Bertagnolli, MD, Dana-Farber Cancer Institute, Boston, MA; Charles David Blanke, MD, Oregon Health and Science University Hospital, Portland, OR; Hanna Sanoff, MD, University of North Carolina at Chapel Hill, Chapel Hill, NC; James Atkins, MD, Bon Secours Health System, Richmond, VA; Blasé Polite, MD, University of Chicago Medical Center, Chicago, IL; Alan P. Venook, MD, University of California San Francisco, San Francisco, CA; Heinz-Josef Lenz, MD, University of Southern California, Los Angeles, CA; and Omar Kabbarah, PhD, ORIC Pharmaceuticals, South San Francisco, CA., Atkins J; Federico Innocenti, MD, PhD, University of North Carolina at Chapel Hill, Chapel Hill, NC; Fang-Shu Ou, PhD, Mayo Clinic Minnesota, Rochester, MN; Xueping Qu, PhD, Genentech, South San Francisco, CA; Tyler Zemla, MS, Mayo Clinic Minnesota, Rochester, MN; Donna Niedzwiecki, PhD, Duke University, Durham, NC; Rachel Tam, PhD and Shilpi Mahajan, PhD, Genentech, South San Francisco, CA; Richard M. Goldberg, MD, West Virginia University Cancer Institute, Morgantown, WV; Monica M. Bertagnolli, MD, Dana-Farber Cancer Institute, Boston, MA; Charles David Blanke, MD, Oregon Health and Science University Hospital, Portland, OR; Hanna Sanoff, MD, University of North Carolina at Chapel Hill, Chapel Hill, NC; James Atkins, MD, Bon Secours Health System, Richmond, VA; Blasé Polite, MD, University of Chicago Medical Center, Chicago, IL; Alan P. Venook, MD, University of California San Francisco, San Francisco, CA; Heinz-Josef Lenz, MD, University of Southern California, Los Angeles, CA; and Omar Kabbarah, PhD, ORIC Pharmaceuticals, South San Francisco, CA., Polite B; Federico Innocenti, MD, PhD, University of North Carolina at Chapel Hill, Chapel Hill, NC; Fang-Shu Ou, PhD, Mayo Clinic Minnesota, Rochester, MN; Xueping Qu, PhD, Genentech, South San Francisco, CA; Tyler Zemla, MS, Mayo Clinic Minnesota, Rochester, MN; Donna Niedzwiecki, PhD, Duke University, Durham, NC; Rachel Tam, PhD and Shilpi Mahajan, PhD, Genentech, South San Francisco, CA; Richard M. Goldberg, MD, West Virginia University Cancer Institute, Morgantown, WV; Monica M. Bertagnolli, MD, Dana-Farber Cancer Institute, Boston, MA; Charles David Blanke, MD, Oregon Health and Science University Hospital, Portland, OR; Hanna Sanoff, MD, University of North Carolina at Chapel Hill, Chapel Hill, NC; James Atkins, MD, Bon Secours Health System, Richmond, VA; Blasé Polite, MD, University of Chicago Medical Center, Chicago, IL; Alan P. Venook, MD, University of California San Francisco, San Francisco, CA; Heinz-Josef Lenz, MD, University of Southern California, Los Angeles, CA; and Omar Kabbarah, PhD, ORIC Pharmaceuticals, South San Francisco, CA., Venook AP; Federico Innocenti, MD, PhD, University of North Carolina at Chapel Hill, Chapel Hill, NC; Fang-Shu Ou, PhD, Mayo Clinic Minnesota, Rochester, MN; Xueping Qu, PhD, Genentech, South San Francisco, CA; Tyler Zemla, MS, Mayo Clinic Minnesota, Rochester, MN; Donna Niedzwiecki, PhD, Duke University, Durham, NC; Rachel Tam, PhD and Shilpi Mahajan, PhD, Genentech, South San Francisco, CA; Richard M. Goldberg, MD, West Virginia University Cancer Institute, Morgantown, WV; Monica M. Bertagnolli, MD, Dana-Farber Cancer Institute, Boston, MA; Charles David Blanke, MD, Oregon Health and Science University Hospital, Portland, OR; Hanna Sanoff, MD, University of North Carolina at Chapel Hill, Chapel Hill, NC; James Atkins, MD, Bon Secours Health System, Richmond, VA; Blasé Polite, MD, University of Chicago Medical Center, Chicago, IL; Alan P. Venook, MD, University of California San Francisco, San Francisco, CA; Heinz-Josef Lenz, MD, University of Southern California, Los Angeles, CA; and Omar Kabbarah, PhD, ORIC Pharmaceuticals, South San Francisco, CA., Lenz HJ; Federico Innocenti, MD, PhD, University of North Carolina at Chapel Hill, Chapel Hill, NC; Fang-Shu Ou, PhD, Mayo Clinic Minnesota, Rochester, MN; Xueping Qu, PhD, Genentech, South San Francisco, CA; Tyler Zemla, MS, Mayo Clinic Minnesota, Rochester, MN; Donna Niedzwiecki, PhD, Duke University, Durham, NC; Rachel Tam, PhD and Shilpi Mahajan, PhD, Genentech, South San Francisco, CA; Richard M. Goldberg, MD, West Virginia University Cancer Institute, Morgantown, WV; Monica M. Bertagnolli, MD, Dana-Farber Cancer Institute, Boston, MA; Charles David Blanke, MD, Oregon Health and Science University Hospital, Portland, OR; Hanna Sanoff, MD, University of North Carolina at Chapel Hill, Chapel Hill, NC; James Atkins, MD, Bon Secours Health System, Richmond, VA; Blasé Polite, MD, University of Chicago Medical Center, Chicago, IL; Alan P. Venook, MD, University of California San Francisco, San Francisco, CA; Heinz-Josef Lenz, MD, University of Southern California, Los Angeles, CA; and Omar Kabbarah, PhD, ORIC Pharmaceuticals, South San Francisco, CA., Kabbarah O; Federico Innocenti, MD, PhD, University of North Carolina at Chapel Hill, Chapel Hill, NC; Fang-Shu Ou, PhD, Mayo Clinic Minnesota, Rochester, MN; Xueping Qu, PhD, Genentech, South San Francisco, CA; Tyler Zemla, MS, Mayo Clinic Minnesota, Rochester, MN; Donna Niedzwiecki, PhD, Duke University, Durham, NC; Rachel Tam, PhD and Shilpi Mahajan, PhD, Genentech, South San Francisco, CA; Richard M. Goldberg, MD, West Virginia University Cancer Institute, Morgantown, WV; Monica M. Bertagnolli, MD, Dana-Farber Cancer Institute, Boston, MA; Charles David Blanke, MD, Oregon Health and Science University Hospital, Portland, OR; Hanna Sanoff, MD, University of North Carolina at Chapel Hill, Chapel Hill, NC; James Atkins, MD, Bon Secours Health System, Richmond, VA; Blasé Polite, MD, University of Chicago Medical Center, Chicago, IL; Alan P. Venook, MD, University of California San Francisco, San Francisco, CA; Heinz-Josef Lenz, MD, University of Southern California, Los Angeles, CA; and Omar Kabbarah, PhD, ORIC Pharmaceuticals, South San Francisco, CA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2019 Sep 01; Vol. 37 (25), pp. 2291-2293. Date of Electronic Publication: 2019 Jul 03.